The core three-panel test asks what the laboratory identified, how pure its analytical signal was, and how much target compound it measured. These are three separate findings. A high purity percentage does not establish the amount in a vial, and a measured amount does not identify every impurity. Read all three results before describing a research peptide as tested.
Use the COA library to open a complete certificate and the COA checker to inspect its issuer evidence. This article concerns research-use-only materials and analytical documentation. It contains no dosing or medical advice.
First identify the sample the laboratory received
Before reading the numbers, compare the sample name, nominal strength, client and lot with the research listing. A report for bulk powder describes a different sample stage from a report for finished vials. Likewise, a single-compound certificate cannot automatically support a blend, and a report for one nominal strength cannot establish the content of another.
Check the dates by role. Receipt, analysis and report issue are separate events. An old analysis does not become a new batch test when a vendor uploads the PDF again. If a sample photograph is present, use it as additional sample-description evidence while retaining the printed identifiers. A matching cap color alone is a weak way to connect material to a lot.
Identity: what analytical comparison was made?
LC-MS combines a separation with mass detection. The resulting mass information can support the assignment of the named peptide. Look for the laboratory's stated identity result and any supporting spectrum. A report should make clear whether its finding is based on mass, retention-time comparison or another method.
Intact mass and sequence confirmation have different scopes. Compounds with the same mass can require additional work to distinguish. Fragment information and suitable reference comparisons can strengthen an assignment, but a reader should not assume those steps occurred merely because the report says “mass spectrometry.” Waters' mass-confirmation study provides a primary example of using accurate mass and fragment information in peptide analysis.
HPLC retention-time identity compares where a sample peak appears with a reference under the method's conditions. It is not an LC-MS result. ZC Labs' reviewed ILS certificates provide a useful example of why this distinction matters: their identity claim uses retention-time matching. The ILS laboratory profile and the laboratory's published peptide methods give context for that method label.
For a report reader, the next step is to preserve the stated scope. Write “identity by retention-time match” when that is the evidence. Write “LC-MS identity” when that is reported. Do not replace either with “complete molecular structure confirmed.”
Purity: understand the percentage's denominator
HPLC-UV measures ultraviolet response after chromatographic separation. For an area-normalized purity result, the calculation compares the main component's integrated peak area with the integrated area included in the analysis. It describes that analytical measurement, rather than weighing every substance in the original container.
Imagine a hypothetical chromatogram with 990 area units assigned to the main peak and ten to other integrated peaks. The main peak represents 99% of that integrated signal. That calculation says nothing by itself about whether the vial contained 5 mg, 10 mg or another amount of the target peptide. Those are content questions requiring a quantitative result.
Resolution also matters. Components that overlap can be difficult to separate in a UV trace. Waters' synthetic-peptide separation application note shows the value of improving chromatographic resolution when investigating impurities. When the source document includes chromatograms, keep them with the headline percentage rather than retaining only a cropped summary.
Do not use HPLC purity to estimate endotoxin or metal contamination. Their relevant measurements come from different assays. A substance can be outside the UV measurement's scope even when it is important to a research workflow.
Measured content: compare like units and sample bases
A quantitative content result should state the amount of the target analyte and its basis. “mg per vial,” “mg/mL” and a bulk assay percentage are different quantities. A report that prints a concentration needs its sample-preparation basis to connect that concentration to total sample content. The vial label alone cannot supply an undocumented laboratory volume.
Content also depends on calibration and the assay's definition of the analyte. Ask which reference standard and calculation basis support the result when the document is unclear. In regulated analytical work, the FDA's method-validation guidance emphasizes evidence that the procedure is suitable for its intended measurement. Merely naming HPLC does not explain every quantitative assumption.
A report can contain an excellent purity result and a materially low content result at the same time. For a hypothetical vial labeled 10 mg and measured at 8 mg, the measurement is 20% below the nominal label. That example is arithmetic, not a vendor finding or a proposed acceptance specification. Read the report's uncertainty and any stated acceptance range before interpreting smaller differences.
“Potency” can also be ambiguous. Some commercial copy uses it for measured content; biological potency refers to activity assessed by an appropriate assay. A mass result should retain its mass label unless the laboratory actually measured biological activity.
Replicates and blends need their own reading
When a certificate lists multiple vials, read the individual results before the average. An average can conceal differences between submitted units. Also distinguish repeat measurements of one prepared sample from separately tested vials. The report's replication scheme determines what kind of consistency evidence is available.
For blends, find the separate identity and amount assigned to each component. A total measured mass cannot show that each ingredient is present at its nominal amount. Similarly, one overall chromatographic purity number should not be silently rewritten as a purity result for every ingredient. Keep “overall” and component-specific findings separate in notes.
These distinctions matter when following BPC-157, Tesamorelin or MOTS-c listings. The comparison page is a route to the exact report. It does not make a different-strength or different-formulation certificate interchangeable with the row under review.
Eight vendor archives to practice on
The following counts come from PeptidePrices' retained evidence as reviewed for this September 25, 2026 series. Verified means the documented issuer-check scope; it is not a new physical sample test performed for this article.
| Vendor archive | What PeptidePrices checked | Useful reading exercise |
|---|---|---|
| Puratek Peptides | 42 of 42 reports matched official records | All 42 include identity, purity and measured content; compare 35 ILS with seven Freedom reports |
| ZC Labs | 69 of 70 certificates matched; one historical no-match | Compare ILS retention-time identity with Freedom LC-MS identity |
| Rebirth Labs | 119 issuer-matched public reports from 123 retained documents | Keep the four unavailable issuer documents outside the public verified count |
| Modern Research Peptides | 124 verified downloadable PDFs from 125 archive records | All 124 have core results; preserve per-vial content when more than one vial is reported |
| Glacier Aminos | 245 exact issuer matches and 25 documentary-only public records | Compare methods across five issuer-verifiable laboratories without merging their scopes |
| Amino Club | 102 issuer matches in 103 records representing 94 documents | Distinguish public records, certificate documents and a summarized assay count |
| Refined BioLabs | 25 issuer-verified records | All 25 have extractable identity, purity and content fields |
| Validated Peptides | 17 of 17 issuer-matched public reports | All 17 document the core three-panel test; extended panels appear on a subset |
A specific example from Rebirth's public archive is report REBI2608310707: its transcribed results identify PT-141, give 99.87% purity and report 9.56 mg measured content. Those three fields answer different questions. Preserve the report's full context, including nominal strength and method, when assessing the amount. A numeric example should never lose its accession when copied into a comparison.
Verify before repeating the result
Use the issuing laboratory's own lookup and compare report number, client, product, lot, dates and values. The Freedom Diagnostics profile explains the issuer behind many examples above. The laboratory's service page identifies HPLC purity, LC-MS identity and net content as distinct outputs.
A correct accession attached to the wrong client or different results needs investigation. A portal that only confirms existence supports a narrower statement than a returned full report. An unavailable portal should remain unavailable in the record; a retained PDF does not become issuer verified merely because its design looks familiar.
Add the panels your evidence question requires
The core three-panel test describes identity, chromatographic purity and amount. To evaluate other report findings, continue with endotoxin testing, sterility and microbial screens, and ICP-MS heavy-metal testing. The complete COA guide brings all five articles together with the laboratory coverage audit and verification workflow.
For a research record, save the exact report and record three separate findings: the identity method and result, the purity method and percentage, and the content value with its unit and sample basis. That small separation makes later comparisons far easier to audit.